Surgery Websites
Transplant Surgery »  Meet the Team »  Hepatology »  Norah A. Terrault, M.D., M.P.H.
Norah A. Terrault, M.D., M.P.H.

Norah A. Terrault, M.D., M.P.H.

Professor of Clinical Medicine & Surgery
Departments of Medicine & Surgery
Director of Viral Hepatitis Research in Liver Transplantation

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 476-2227
415-476-0659
norah.terrault@ucsf.edu
 
Open Popup

1985 B.MSc., University of Alberta

1987 M.D., University of Alberta

1997 M.P.H. University of California, Berkeley

  • 1987-88 Internship, University of Toronto
  • 1988-91 Internal Medicine, University of Toronto
  • 1991-93 Gastroenterology, University of Toronto
  • 1994-95 Clinical Hepatology, Division of Gastroenterology, University of Toronto

  • 1995-97 Research Hepatology, Division of Gastroenterology, UCSF Medical Center

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Gastroenterology
  • UCSF Liver Center
  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Liver Injury and Repair

Dr. Norah Terrault is a hepatologist or liver specialist who is recognized internationally for the treatment of viral hepatitis and liver transplantation. Her research includes the study of viral hepatitis and its progression and treatment, especially in liver transplant patients. Her research includes several clinical trials related to preventing and treating chronic hepatitis C and B. Her studies in this area have been presented to the American Association for the Study of Liver Diseases, the leading organization for research in liver disease.

Terrault completed medical training at the University of Alberta and specialty medical training in Internal Medicine and Gastroenterology at the University of Toronto, both in Canada. Her post-doctoral fellowship in hepatology and viral hepatitis was completed at the University of California, San Francisco while earning a concurrent master's degree in public health from the University of California at Berkeley. She joined the medical staff at UCSF Medical Center in 1997.

My research focuses on the natural history and treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), particularly in special populations, including those undergoing liver transplantation. Work in progress addresses the natural history of post-transplant disease and specific therapies to prevent infection or modify HCV and HBV disease progression and loss of grafts from recurrent disease.

Our virological analyses are focused on characterization of viral mutations that occur in liver transplant recipients receiving antiviral therapies and assessment of the effect of these variant viruses on the natural history and severity of disease post-transplantation. Knowledge of these factors may allow improved organ allocation by identifying subsets of patients with HCV recurrence in liver grafts who would be favorable or unfavorable candidates for retransplantation. 

Data provided by UCSF Profiles, powered by CTSI
ORCID iD: 0000-0003-4143-1950 Additional info
  • Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2002
    -
    Jun 2024
    Principal Investigator
  • Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    Sponsor:
    Sponsor ID:
    Funding Period:
    Sep 2008
    -
    May 2020
    Principal Investigator
  • Bay Area Hepatitis C Cooperative Research Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jun 2010
    -
    May 2015
    Co-Investigator
  • General Clinical Research Center
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 1974
    -
    Mar 2009
    Co-Investigator
  • Resistance to Antiviral Therapy in Chronic Hepatitis C
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 2001
    -
    Apr 2007
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 319
Data provided by UCSF Profiles, powered by CTSI
  1. Reply to 'Evidence against in utero transmission of hepatitis B virus'. Nat Rev Gastroenterol Hepatol. 2021 Apr 22. View in PubMed
  2. Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons. AIDS Res Hum Retroviruses. 2021 Apr 01. View in PubMed
  3. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Non-viral Liver Disease is the Leading Indication for Liver Transplant in the U.S. in Persons Living with Human Immunodeficiency Virus. Am J Transplant. 2021 Mar 22. View in PubMed
  4. Retail Alcohol and Tobacco Sales During COVID-19. Ann Intern Med. 2021 Mar 02. View in PubMed
  5. Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee WM, Kleiner DE, Lok AS, Kaestner KH, Chang KM. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver. JCI Insight. 2021 Feb 23. View in PubMed
  6. View All Publications

 

Site Directory
    X